Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Collier

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
Science Advances|November 23, 2022
A sublingual nanofiber vaccine to prevent urinary tract infectionsSean H Kelly, Nicole L Votaw, Benjamin J Cossette, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 2, 2022
Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA TrialJeffrey R Curtis, Bradley Stolshek, Paul Emery, et al.
Macromolecular Bioscience|October 17, 2018
Self-Assembling Peptide Gels for 3D Prostate Cancer Spheroid CultureKelly M Hainline, Fangqi Gu, Jacqueline F Handley, et al.
Arthritis Research & Therapy|April 29, 2017
Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritisGeorge W Reed, David H Collier, Andrew S Koenig, et al.
Clinical Therapeutics|July 12, 2014
Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claimsJeffrey R Curtis, Vernon F Schabert, David J Harrison, et al.
Clinical Rheumatology|March 9, 2017
Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registryLeslie R Harrold, Bradley S Stolshek, Sabrina Rebello, et al.
Journal of the American Academy of Dermatology|January 19, 2016
Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasisAmy S Paller, Elaine C Siegfried, David M Pariser, et al.
The Journal of Rheumatology|October 3, 2017
Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease ActivityLeslie R Harrold, Bradley S Stolshek, Sabrina Rebello, et al.
The British Journal of Dermatology|February 15, 2017
Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumabJ Bagel, S Tyring, K C Rice, et al.
RMD Open|January 16, 2021
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combinationVibeke Strand, Philip J Mease, Ervant J Maksabedian Hernandez, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Science Advances|November 23, 2022
A sublingual nanofiber vaccine to prevent urinary tract infectionsSean H Kelly, Nicole L Votaw, Benjamin J Cossette, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 2, 2022
Effects of Disease-Worsening Following Withdrawal of Etanercept or Methotrexate on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis: Results From the SEAM-RA TrialJeffrey R Curtis, Bradley Stolshek, Paul Emery, et al.
Macromolecular Bioscience|October 17, 2018
Self-Assembling Peptide Gels for 3D Prostate Cancer Spheroid CultureKelly M Hainline, Fangqi Gu, Jacqueline F Handley, et al.
Arthritis Research & Therapy|April 29, 2017
Clinical and demographic factors associated with change and maintenance of disease severity in a large registry of patients with rheumatoid arthritisGeorge W Reed, David H Collier, Andrew S Koenig, et al.
Clinical Therapeutics|July 12, 2014
Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claimsJeffrey R Curtis, Vernon F Schabert, David J Harrison, et al.
Clinical Rheumatology|March 9, 2017
Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registryLeslie R Harrold, Bradley S Stolshek, Sabrina Rebello, et al.
Journal of the American Academy of Dermatology|January 19, 2016
Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasisAmy S Paller, Elaine C Siegfried, David M Pariser, et al.
The Journal of Rheumatology|October 3, 2017
Rebound in Measures of Disease Activity and Symptoms in Corrona Registry Patients with Psoriatic Arthritis Who Discontinue Tumor Necrosis Factor Inhibitor Therapy after Achieving Low Disease ActivityLeslie R Harrold, Bradley S Stolshek, Sabrina Rebello, et al.
The British Journal of Dermatology|February 15, 2017
Open-label study of etanercept treatment in patients with moderate-to-severe plaque psoriasis who lost a satisfactory response to adalimumabJ Bagel, S Tyring, K C Rice, et al.
RMD Open|January 16, 2021
Patient-reported outcomes data in patients with psoriatic arthritis from a randomised trial of etanercept and methotrexate as monotherapy or in combinationVibeke Strand, Philip J Mease, Ervant J Maksabedian Hernandez, et al.
Pageof 24